Hørsholm, Denmark

Peter L Sivertsen

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter L Sivertsen. Retrieved from https://idiyas.com/inventor/peter-l-sivertsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter L. Sivertsen

Introduction

Peter L. Sivertsen is a notable inventor based in Hörsholm, Denmark. He has made significant contributions to the field of chemistry, particularly in the production of specialized compounds. His work is recognized for its potential applications in various industries, including pharmaceuticals.

Latest Patents

Peter L. Sivertsen holds 1 patent for a process that involves the production of N-benzyl azetidine-2-carboxylic acid alkylphenyl or alkyl esters. This innovative process includes the reaction of an optionally substituted alkylphenyl or an optionally substituted alkyl, 2-bromo-4-chlorobutyrate with an optionally substituted benzylamine. This method may serve as a crucial step in the overall production of azetidine-2-carboxylic acid.

Career Highlights

Sivertsen is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge research and development projects that aim to improve health outcomes through innovative solutions.

Collaborations

One of his notable collaborators is Bo Lindqvist, with whom he has worked closely on various projects. Their partnership exemplifies the collaborative spirit that drives innovation in the scientific community.

Conclusion

Peter L. Sivertsen's contributions to the field of chemistry and his innovative patent highlight his role as a significant inventor. His work continues to influence the development of new processes in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…